Profil:
Synektik SASynektik posts PLN 30.5 mln attrib. net profit in Q3 of 2024/25 financial year
Listed radiopharmaceuticals firm Synektik posted PLN 30.5 million (EUR 7.1 mln) attributable net profit in the third quarter of the financial year 2024/2025, above the consensus for PLN 26.2 million (EUR 6.1 mln), the company said in the report.
PLN mln
3Q2024/25 | results | consensus | difference | y/y | q/q | YTD2024/25 | y/y |
Revenues | 154.2 | 148.3 | 4.0% | 24.4% | 23.7% | 482.1 | -0.2% |
EBITDA | 41.6 | 38.7 | 7.6% | 31.2% | 36.8% | 122.5 | 12.1% |
EBIT | 36.4 | 30.2 | 20.5% | 30.9% | 43.3% | 107.5 | 10.1% |
Attrib. net profit | 30.5 | 26.2 | 16.4% | 35.6% | 64.0% | 85.7 | 13.2% |
EBITDA margin | 27.0% | 25.8% | 1.17 | 1.41 | 2.60 | 25.41% | 2.78 |
EBIT margin | 23.6% | 20.4% | 3.22 | 1.19 | 3.24 | 22.30% | 2.09 |
net margin | 19.8% | 17.3% | 2.45 | 1.63 | 4.86 | 17.78% | 2.10 |
doa/ nl/